Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1
We offer a comprehensive treatment plan that includes nutritional counseling and medication if needed
Retatrutide adds glucagon receptor activation to the mix, which drives additional lipolysis and energy expenditure beyond what GLP-1 and GIP agonism provide alone
Like other injectable peptide therapies in its class, retatrutide is administered subcutaneously meaning it is injected into the fatty tissue just beneath the skin, rather than into muscle or a vein
Realistic outcomes lean toward reduced shedding and improved hair quality rather than dramatic regrowth, and hair-related changes are consistently the slowest of Klows outcomes commonly 8-16 weeks minimum, mirroring the multi-month evaluation windows used for approved hair therapies generally
This period establishes the gene expression changes that drive collagen synthesis, inflammation reduction, and tissue remodeling